3-FPM: Difference between revisions

>Avogato
mNo edit summary
>Myriadis
m Added legal status in France
 
(23 intermediate revisions by 13 users not shown)
Line 1: Line 1:
{{Distinguish|3F-Phenetrazine}}
{{SummarySheet}}
{{SummarySheet}}
{{SubstanceBox/3-FPM}}
{{SubstanceBox/3-FPM}}
'''3-Fluorophenmetrazine''' (also known as '''3F-Phenmetrazine''', '''PAL-593''', and '''3-FPM''') is a novel [[psychoactive class::stimulant]] substance of the [[Chemical class::phenylmorpholine]] class. 3-FPM is a derivative of [[phenmetrazine]], a once-popular stimulant substance that was clinically used as an anorectic in Europe in the 1950s.<ref>{{cite book | vauthors=((Kalant, O. J.)) | date= 1966 | title=The amphetamines; toxicity and addiction | publisher=[Springfield, Ill.] Thomas [Toronto, Univ. of Toronto Press] | url=http://archive.org/details/amphetaminestoxi0000unse}}</ref> It produces its activity by increasing the levels of [[serotonin]], [[dopamine]], and [[norepinephrine]] in the brain.


'''3-Fluorophenmetrazine''' (also known as '''3F-Phenmetrazine''', '''PAL-593''', and '''3-FPM''') is a novel [[psychoactive class::stimulant]] substance of the [[Chemical class::phenylmorpholine]] class. 3-FPM is a derivative of [[phenmetrazine]], a once-popular stimulant substance that was clinically used as an anorectic in Europe in the 1950s.<ref>Kalant, Oriana Josseau (1966). The Amphetamines: Toxicity and Addiction. ISBN 0-398-02511-8.</ref> It produces its activity by increasing the levels of [[serotonin]], [[dopamine]], and [[norepinephrine]] in the brain.  
The synthesis and pharmacology of 3-FPM was first reported in a patent filed in 2011.<ref>{{Citation | vauthors=((Blough, B. E.)), ((Rothman, R.)), ((Landavazo, A.)), ((Page, K. M.)), ((Decker, A. M.)) | title=Phenylmorpholines and analogues thereof | url=https://patents.google.com/patent/US9617229B2/en}}</ref> Reports of human use first surfaced in early 2015 after it appeared for sale on the online [[research chemical]] market.  


The synthesis and pharmacology of 3-FPM was first reported in a patent filed in 2011.<ref>Blough, B. E., Rothman, R., Landavazo, A., Page, K. M., & Decker, A. M. (2017). U.S. Patent No. 9,617,229. Washington, DC: U.S. Patent and Trademark Office.</ref> Reports of human use first surfaced in early 2015 after it appeared for sale on the online [[research chemical]] market.  
[[Subjective effects]] include [[stimulation]], [[focus enhancement|enhanced focus]] and [[motivation enhancement|motivation]], [[thought acceleration]], and [[euphoria]]. Users commonly report that 3-FPM produces classical stimulant effects comparable to those of amphetamine. Many reports describe 3-FPM as having a relatively subtle and controlled stimulant effect which produces less nervousness, insomnia and euphoria than other stimulants, which makes it suitable as a study-aid or productivity-enhancer. A few but significant number of anecdotal reports indicate some people experience serious nervous system reactions to 3-FPM<ref>{{Citation | vauthors=Sisquitch | year=2021 | title=I had the 3-FPM that caused mild paralysis and damage to a Reddit user’s peroneal nerve NMR tested. Results in the description. | url=https://www.reddit.com/r/researchchemicals/comments/l4yvh5/i_had_the_3fpm_that_caused_mild_paralysis_and/}}</ref>.


User reports indicate that 3-FPM produces classical stimulant effects comparable to those of amphetamine. Common effects include [[stimulation]], [[focus enhancement|enhanced focus]] and [[motivation enhancement|motivation]], [[thought acceleration]], and [[euphoria]]. Many reports describe 3-FPM as having a relatively subtle and controlled stimulant effect which produces less nervousness, insomnia and euphoria than other stimulants, which makes it suitable as a study-aid or productivity-enhancer.
Very little data exists about the pharmacological properties, metabolism, and toxicity of 3-FPM. Due to the lack of information on its properties, it is highly advised to use [[harm reduction practices]] if using this substance.  
 
Very little data exists about the pharmacological properties, metabolism, and toxicity of 3-FPM. Due to the lack of information on its properties, it is highly advised to use [[harm reduction practices]] if using this substance.


==Chemistry==
==Chemistry==
3-Fluorophenmetrazine (3-FPM) is a synthetic molecule of the [[amphetamine]] family.  Molecules of the amphetamine class contain a phenethylamine core featuring a phenyl ring bound to an amino (NH2) group through an ethyl chain with an additional methyl substitution at R<sub>α</sub>. Amphetamines are alpha-methylated phenethylamines. 3-FPM contains a fluorine atom attached at R<sub>3</sub> of the phenyl ring. Additionally, part of its amphetamine skeleton is incorporated into a morpholine ring. At R<sub>2</sub> of its chain, an oxygen group is bound -- this oxygen group is linked by an ethyl chain to the terminal amine of the amphetamine chain to form a morpholine group. 3-FPM is a fluorinated derivative of [[phenmetrazine]].
3-Fluorophenmetrazine (3-FPM) is a synthetic molecule of the [[Chemical class::Substituted amphetamine|amphetamine]] family.  Molecules of the amphetamine class contain a [[phenethylamine]] core featuring a phenyl ring bound to an amino (NH2) group through an ethyl chain with an additional methyl substitution at R<sub>α</sub>. Amphetamines are alpha-methylated phenethylamines. 3-FPM contains a fluorine atom attached at R<sub>3</sub> of the phenyl ring. Additionally, part of its amphetamine skeleton is incorporated into a morpholine ring. At R<sub>2</sub> of its chain, an oxygen group is bound -- this oxygen group is linked by an ethyl chain to the terminal amine of the amphetamine chain to form a morpholine group. 3-FPM is a fluorinated derivative of [[phenmetrazine]].


==Pharmacology==
==Pharmacology==
Line 23: Line 23:
|-
|-
|-
|-
|'''Compounds >'''<br>'''Neurotransmitters V'''||[[PAL-593]]||[[Phenmetrazine]]
|'''Compounds >'''<br>'''Neurotransmitters V'''||3-FPM||[[Phenmetrazine]]
|-
|-
|[[dopamine|DA Release]]||43||87
|[[dopamine|DA Release]]||43||87
Line 31: Line 31:
|[[noradrenaline|NE Release]]||30||38
|[[noradrenaline|NE Release]]||30||38
|}
|}
  ||<ref>https://www.google.com/patents/US20130203752</ref>
  ||<ref>{{Citation | vauthors=((Blough, B. E.)), ((Rothman, R.)), ((Landavazo, A.)), ((Page, K. M.)), ((Decker, A. M.)) | title=Phenylmorpholines and analogues thereof | url=https://patents.google.com/patent/US20130203752/en}}</ref>
|}
|}


==Subjective effects==
==Subjective effects==
{{EffectStub}}
According to anecdotal reports, 3-FPM is considered to be more subtle in its effects when compared to other stimulants and produces less [[anxiety|nervousness]], [[euphoria]], and [[wakefulness|insomnia]] than substances of the [[substituted amphetamine]] class, leading to its adoption as a study and productivity-enhancing drug as opposed to the more typical recreational stimulant with pronounced [[euphoric]] properties.  
According to anecdotal reports, 3-FPM is considered to be more subtle in its effects when compared to other stimulants and produces less [[anxiety|nervousness]], [[euphoria]], and [[wakefulness|insomnia]] than substances of the [[substituted amphetamine]] class, leading to its adoption as a study and productivity-enhancing drug as opposed to the more typical recreational stimulant with pronounced [[euphoric]] properties.  


Line 53: Line 54:
*'''[[Effect::Vasoconstriction]]''' {{citation needed}}
*'''[[Effect::Vasoconstriction]]''' {{citation needed}}
*'''[[Effect::Increased libido]]''' - 3-FPM is known for having aphrodisiac properties and is said to enhance sex drive and improve sexual performance.{{citation needed}}
*'''[[Effect::Increased libido]]''' - 3-FPM is known for having aphrodisiac properties and is said to enhance sex drive and improve sexual performance.{{citation needed}}
*'''[[Effect::Decreased libido]]''' - 3-FPM is known for increasing sexual activity. But while being a CNS stimulant vasoconstriction that occurs with stimulants can make sexual activity more strenuous
*'''[[Effect::Decreased libido]]''' - 3-FPM is known for increasing sexual activity. But while being a CNS stimulant vasoconstriction that occurs with stimulants can make sexual activity more strenuous{{citation needed}}
*'''[[Effect::Pupil dilation]]'''
*'''[[Effect::Pupil dilation]]'''
*'''[[Effect::Teeth grinding]]''' - This component can be considered to be less intense when compared with that of [[MDMA]] and many other stimulants.
*'''[[Effect::Teeth grinding]]''' - This component can be considered to be less intense when compared with that of [[MDMA]] and many other stimulants.
Line 75: Line 76:
}}
}}
{{effects/aftereffects|
{{effects/aftereffects|
 
Although many report 3-FPM to have minor comedowns, many also report redosing can produce moderate to full on of the effects which occur during the [[offset]] of a [[stimulant]] experience generally feel negative and uncomfortable in comparison to the effects which occurred during its [[peak]]. This is often referred to as a "comedown" and occurs because of [[neurotransmitter]] depletion. Its effects commonly include:
The effects which occur during the [[offset]] of a [[stimulant]] experience generally feel negative and uncomfortable in comparison to the effects which occurred during its [[peak]]. This is often referred to as a "comedown" and occurs because of [[neurotransmitter]] depletion. Its effects commonly include:


*'''[[Effect::Anxiety]]'''
*'''[[Effect::Anxiety]]'''
Line 85: Line 85:
*'''[[Effect::Thought deceleration]]'''  
*'''[[Effect::Thought deceleration]]'''  
*'''[[Effect::Wakefulness]]'''
*'''[[Effect::Wakefulness]]'''
 
*'''[[Effect::Derealization]]'''
}}
}}


Line 95: Line 95:
}}
}}
===Experience reports===
===Experience reports===
There are currently no anecdotal reports which describe the effects of this compound within our [[experience index]]. Additional experience reports can be found here:
Anecdotal reports which describe the effects of this compound within our [[experience index]] include:
{{#ask: [[Category:3-FPM]][[Category:Experience]]|format=ul|Columns=1}}
Additional experience reports can be found here:


*[https://www.erowid.org/experiences/subs/exp_3FPhenmetrazine.shtml Erowid Experience Vaults: 3-FPM]
*[https://www.erowid.org/experiences/subs/exp_3FPhenmetrazine.shtml Erowid Experience Vaults: 3-FPM]
Line 120: Line 122:
==Legal status==
==Legal status==


*'''Germany''': 3-FPM is controlled under the NpSG (''New Psychoactive Substances Act'')<ref>{{cite web|url=https://www.gesetze-im-internet.de/npsg/anlage.html|title=Anlage NpSG|publisher=Bundesministerium der Justiz und für Verbraucherschutz|access-date=December 19, 2019|language=de}}</ref> as of November 26, 2016.<ref>{{cite web|url=https://www.bgbl.de/xaver/bgbl/start.xav?startbk=Bundesanzeiger_BGBl&jumpTo=bgbl116s2615.pdf#__bgbl__%2F%2F*%5B%40attr_id%3D%27bgbl116s2615.pdf%27%5D__1576017393518|title=Gesetz zur Bekämpfung der Verbreitung neuer psychoaktiver Stoffe|publisher=Bundesanzeiger Verlag|access-date=December 19, 2019|language=de}}</ref> Production and import with the aim to place it on the market, administration to another person and trading is punishable. Possession is illegal but not penalized.<ref>{{cite web|url=https://www.gesetze-im-internet.de/npsg/__4.html|title=§ 4 NpSG|publisher=Bundesministerium der Justiz und für Verbraucherschutz|access-date=December 19, 2019|language=de}}</ref>
*'''France''': As of december 2024, 3-FPM is not explicitly scheduled. It is thus legal to possess, although in a grey area.<ref>{{Citation | title=Arrêté du 22 février 1990 fixant la liste des substances classées comme stupéfiants  | url=https://www.legifrance.gouv.fr/loda/id/JORFTEXT000000533085/2020-11-20/}}</ref>
*'''Israel''': 3-FPM is illegal to buy, sell or possess in Israel as of 2017.<ref>https://www.nevo.co.il/law_html/Law01/P170_001.htm</ref>
*'''Germany''': 3-FPM is controlled under the NpSG (''New Psychoactive Substances Act'')<ref>{{cite web|url=https://www.gesetze-im-internet.de/npsg/anlage.html|title=Anlage NpSG|publisher=Bundesministerium der Justiz und für Verbraucherschutz|access-date=December 19, 2019|language=de}}</ref> as of November 26, 2016.<ref>{{cite web|url=https://www.bgbl.de/xaver/bgbl/start.xav?startbk=Bundesanzeiger_BGBl&jumpTo=bgbl116s2615.pdf#__bgbl__%2F%2F*%5B%40attr_id%3D%27bgbl116s2615.pdf%27%5D__1576017393518|title=Gesetz zur Bekämpfung der Verbreitung neuer psychoaktiver Stoffe|publisher=Bundesanzeiger Verlag|access-date=December 19, 2019|language=de}}</ref> As of 2022 due to changes in the NpSG it's legal again if sold only for research purposes.
*'''Israel''': 3-FPM is illegal to buy, sell or possess in Israel as of 2017.<ref>{{Citation | title=פקודת הסמים המסוכנים [נוסח חדש], תשל"ג-1973 | url=https://www.nevo.co.il/law_html/Law01/P170_001.htm}}</ref>
*'''Sweden''': The public health agency suggested the classification of the drug as an illegal narcotic on June 1, 2015.<ref>http://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2015/juni/23-nya-amnen-kan-klassas-som-narkotika-eller-halsofarlig-vara</ref>
*'''Sweden''': The public health agency suggested the classification of the drug as an illegal narcotic on June 1, 2015.<ref>http://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2015/juni/23-nya-amnen-kan-klassas-som-narkotika-eller-halsofarlig-vara</ref>
*'''Switzerland''': 3-FPM was added to the list of controlled substances in December 2015.<ref>https://www.admin.ch/opc/de/official-compilation/2015/5093.pdf</ref>
*'''Switzerland''': 3-FPM is a controlled substance specifically named under Verzeichnis E. It was added to the list of controlled substances in December 2015.<ref>{{cite web|url=https://www.admin.ch/opc/de/classified-compilation/20101220/index.html|title=Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien|publisher=Bundeskanzlei [Federal Chancellery of Switzerland]|access-date=January 1, 2020|language=de}}</ref>
*'''United Kingdom''': 3-FPM is illegal to produce, supply, or import under the Psychoactive Substance Act, which came into effect on May 26th, 2016.<ref>Psychoactive Substances Act 2016 (Legislation.gov.uk) | http://www.legislation.gov.uk/ukpga/2016/2/contents/enacted</ref>
*'''Turkey:''' 3-FPM is a classed as drug and is illegal to possess, produce, supply, or import.<ref name="Bakanlar Kurulu Kararı - Karar Sayısı : 2016/9712">https://resmigazete.gov.tr/eskiler/2017/01/20170112-8.pdf</ref>
*'''United States''': 3-FPM may be considered to be an analogue of phenmetrazine, a Schedule II drug, under the Federal Analogue Act if it is intended for human consumption.{{citation needed}}
*'''United Kingdom''': 3-FPM is illegal to produce, supply, or import under the Psychoactive Substance Act, which came into effect on May 26th, 2016.<ref>{{Citation | title=Psychoactive Substances Act 2016 | url=https://www.legislation.gov.uk/ukpga/2016/2/contents/enacted}}</ref>
*'''United States''': 3-FPM may be considered to be an analogue of phenmetrazine, a Schedule II drug<ref>https://www.deadiversion.usdoj.gov/schedules/orangebook/c_cs_alpha.pdf</ref>, under the Federal Analogue Act if it is intended for human consumption.<ref>{{Citation | title=21 U.S. Code § 813 - Treatment of controlled substance analogues | url=https://www.law.cornell.edu/uscode/text/21/813}}</ref> It is an illegal Schedule I controlled substance in the state of Virginia, as well as its isomers such as 4-FPM.<ref>https://law.lis.virginia.gov/vacode/title54.1/chapter34/section54.1-3446/#:~:text=5.%20Unless%20specifically,name%3A%203%2Dfluorophenmetrazine)%3B</ref>


==See also==
==See also==
Line 148: Line 152:
<references />
<references />


[[Category:Substance]]
[[Category:Psychoactive substance]]
[[Category:Psychoactive substance]]
[[Category:Amphetamine]]
[[Category:Phenylmorpholine]]
[[Category:Stimulant]]
[[Category:Stimulant]]
[[Category:Phenethylamine]]
[[Category:Amphetamine]]
[[Category:Phenylmorpholines]]
[[Category:Research chemical]]
[[Category:Research chemical]]


{{#set:Featured=true}}
{{#set:Featured=true}}
Retrieved from "http://psy.st/wiki/3-FPM"